Scimplify
Develops manufacturing processes for specialty chemicals and critical materials in its own labs in Bengaluru and Hyderabad, then transfers them to a network of more than 500 partner factories. Its platform, Scinode, runs separate agents for research, manufacturing and quality control, choosing production routes and plants and tracking regulatory requirements.
Money and evidence
No research by this company is on the record yet.
Rounds and research, on one timeline
- 2026-10-14Strategic roundRound
$25M$250M post · stated by TechCrunch, from a person familiar with the transaction
For: about $7.5M to expand into the US, including building out its manufacturing network there, and about $2M for further development of the Scinode platform
Manufacturing and scale-upCommercial roll-outModels and platform
TechCrunch alone reported the round, with co-founder Sachin Santhosh on the record, and no company release was found; it calls the round an all-equity strategic round rather than giving it a letter. The company declined to disclose a valuation, so the $250M post-money is one person's account to TechCrunch. the company gave total equity raised as $80M and said the use of proceeds could change.
Lead · Hitachi VenturesHenkelTeknor ApexExisting investor · Accel IndiaExisting investor · Bertelsmann India InvestmentsExisting investor · OmnivoreExisting investor · 3one4 Capital
Announced by the company · techcrunch.com ↗On the timeline →
Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.
Its investors also backed
Other companies on this page whose rounds name the same investor.
- Hitachi VenturesBioptimus